HSBC’s China tie set to drag the shares further

HSBC’s best conditions to cut costs look to have passed.

HSBC’s best conditions for cost cutting may now have passed.


HSBC shares have dropped as much as 4.6% on Tuesday, the most in almost two-years to the day, echoing the market’s reaction to disappointing full-year earnings report in 2017. Then as now, unsatisfactory cost results were partly to blame. Naturally, investors are looking across the sector too, with shares in more ‘locally’ focused rivals Lloyds and closer peer, Barclays both losing traction and Europe’s broadest bank sector index also underperforming.


It’s difficult to read the bank’s comments accompanying lower than forecast underlying income of $19.9bn as a wake-up call. Recent quarterly reports from continental lenders have been patchy at best whilst China’s economic counters have been deteriorating for over a year. But the sector chill is palpable enough given HSBC’s unique insights into challenges for European lenders in the world’s second-largest economy. “China remains subject to domestic and external pressures” said HSBC’s chairman, though he added “we expect it to maintain strong growth”.


Elsewhere, the group’s CEO pledged a “proactive” approach to costs and investments, whilst drawing the line at ‘harmful’ “short-term” decisions. It’s a signal that the best conditions for expenditure may now have passed, after reported operating expenses fell 1% to $34.7bn, but "mainly" due to lack of "costs to achieve expenditure in 2017". In other words, the absence of weighty expenses was a discrete advantage in 2018. With profits adjusted for further one-offs, including FX, rising just 3% and below forecast on all basis, CEO John Flint’s goal of getting cost growth to below underlying earnings growth looks set to remain elusive.


In 2018 at least, any negative impact on attributable capital was contained. Dividends were largely in line with expectations. But the core capital ratio retreated 50 basis points to 14%, calling the rate at which HSBC pay outs have accelerated over the last few years (including buybacks) into question. This thinking helps explain why HSBC stock is lagging more domestically focused large rivals so far year, trading down about 2% since the end of December. That compares with a rise of 12% by Lloyds and RBS’s 17% gain. After all, EPS growth at Europe’s largest bank has latterly been projected to be 11.4 times the value its shares, well above most of the competition. HSBC stock could struggle to ditch a negative bias anytime soon.

Normalised share price chart [19/02/2019 15:10]

Source: Refinitiv/City Index

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.